call us : 
send a message : 
Name: paracetamol CAS No.: 103-90-2 Appearance: Colorless crystalline powder Molecular formula: C8H9NO2 Molecular Weight: 151.163 Melting point:168°C-172℃ PACKAGE:25KGS/BAG
Name:Vitamin B1, Thiamine hydrochloride, Vitamin HCL Appearance: white or faintly yellow, crystalline powder CAS No.:50-81-7 Standard:BP2018/EP9.2 Molecular formula: C12H17ClN4OS·HCl
Name: Paracetamol CAS No.: 103-90-2 Appearance: White crystal powder Molecular formula: C8H9NO2 Molecular Weight: 151.1649 Density: 1.293 g/cm3 Melting point: 168-172℃ Water solubility: 14 g/L (20℃) Water solubility: 14 g/L (20 ºC)
Name: Vitamin C, L-Ascorbic acid Specfication: 35% feed grade CAS No.: 50-81-7 Molecular formula: C6H8O6 Appearance: A almost white or light yellow powder Usage: Animal Feed Additive
Name: Sodium Benzoate CAS No.: 532-32-1 EINECS No：208-534-8 Appearance：White granules or crystalline powder Molecular formula: C7H5NaO2 Molecular Weight: 144.1032 Density: 1.44 g/cm³ Melting point: 300℃ Boiling point: 249.3°C at 760 mmHg Flash point: 111.4°C Water solubility: soluble Vapor Pressure: 0.0122mmHg at 25°C
Anhui Sinotech company strictly select GMP products, support customer registration , and provide professional services to chemical customers in the global market.Purchase Sodium Benzoate Ball/Granular CAS NO.:532-32-1,inquiry Anhui Sinotech . Name: Sodium Benzoate Ball/Granular CAS No.: 532-32-1 Molecular formula: C7H5NaO2 Molecular Weight: 144.1032 Melting point: >300°C Boiling point: 249.3°C at 760 mmHg Density：1,44 g/cm3 Molecular structure: Description: Sodium benzoate balls/granules CAS NO.: 532-32-1, is an organic substance. It is white particles. Odorless or slightly benzoin smell. It has a slightly sweet and astringent taste. It is stable in the air, easily soluble in water, and soluble in ethanol, glycerol and methanol. After entering the body, sodium benzoate undergoes a biotransformation process and is excreted with urine without accumulating in the body. As long as it is within the normal dosage range, it is harmless to t...
Welcome to 135th China Import and Export Fair Dear Sir or Madam, The 135th Canton Fair is scheduled to open on April 15, featuring continuous optimization of exhibition structure, various premi...
The Health Canada’s Pest Management Regulatory Agency (PMRA) has recently published the re-evaluation project plan for Zoxamide. Zoxamide is a Benzamide Fungicide used to control oomycete diseases (for example, late blight and downy mildew). Zoxamide is currently registered for use on grape, bulb onion and potato. It is registered for application using ground and aerial equipment.
The re-evaluation project plan outlines the timeline, the anticipated
areas of focus for the risk assessments, and the data requirements for
the re-evaluation of zoxamide.
Anticipated Re-evaluation Timeline
The re-evaluation of zoxamide is defined as a Category 1 as described in
Regulatory Directive DIR2016-04, Management of Pesticides Re-evaluation
Policy. For this re-evaluation, 980 calendar days are required between
re-evaluation initiation and publication of the proposed decision.
Currently, a proposed re-evaluation decision for zoxamide is anticipated
to be published for consultation by January 2020. The re-evaluation
timeline may be updated if, during the risk assessment, the PMRA
identifies additional areas of focus that should be considered.
Human Health Risk Assessment
New assessments will be conducted for dietary exposure. Existing
assessments with minor updates are considered to be adequate to support
the re-evaluation of zoxamide for the other aspects of human health
assessment.
Environmental Risk Assessment
New assessments will be conducted for environmental fate, water modelling and environmental exposure.
Value
The value of zoxamide will be considered. The viability of alternatives
will be examined for certain uses if risks of concern requiring
mitigation are identified.
Data Requirements
The PMRA has identified the need for the technical registrant to provide
data for zoxamide related to environmental toxicology and fate.
Relevant data/studies were requested from the technical registrant. A
summary of the data call-in is found in the PMRA’s Public Registry. For a
list of data categories that were required, see Appendix I. In
addition, information regarding the registered use pattern was requested
and received by the registrant, to inform the risk assessments.
安徽施泰化工有限公司
online service
+8613866722531
pweiping@techemi.com
pweiping
+8613866722531